Stock Information

• Akebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call Transcript
  Thu, May 7, 2026 3:51 PM
• Transcript : Akebia Therapeutics, Inc., Q1 2026 Earnings Call, May 07, 2026
  Thu, May 7, 2026 3:50 PM
• Akebia Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
  Thu, May 7, 2026 11:40 AM
• Akebia Therapeutics: Q1 Earnings Snapshot
  Thu, May 7, 2026 7:12 AM
• Akebia Therapeutics Q1 EPS $(0.03), Inline, Sales $53.544M Beat $51.668M Estimate
  Thu, May 7, 2026 7:05 AM
• Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights
  Thu, May 7, 2026 7:03 AM
• Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  Mon, May 4, 2026 4:06 PM
• Akebia Therapeutics Announces Publication Of Post-Hoc Win Statistics Analysis Of All-Cause Mortality And Hospitalization From Its Global Phase 3 INNO2VATE Program In The Journal Of The American Society Of Nephrology
  Mon, May 4, 2026 8:10 AM
• Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology
  Mon, May 4, 2026 8:01 AM

Financial data not available